Thermo Fisher Scientific ...

NYSE: TMO · Real-Time Price · USD
491.46
6.42 (1.32%)
At close: Aug 15, 2025, 2:30 PM

Thermo Fisher Scientific Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 28, 2025 Mar 29, 2025 Dec 31, 2024 Sep 28, 2024 Jun 29, 2024 Mar 30, 2024 Dec 31, 2023 Sep 30, 2023 Jul 1, 2023 Apr 1, 2023 Dec 31, 2022 Oct 1, 2022 Jul 2, 2022 Apr 2, 2022 Dec 31, 2021 Oct 2, 2021 Jul 3, 2021 Apr 3, 2021
Net Income
6.59B 6.53B 6.34B 6.14B 6.22B 6.03B 6B 5.94B 5.73B 6.03B 6.96B 7.05B 7.45B 7.61B 7.73B 8.56B 8.6B 7.92B
Depreciation & Amortization
2.87B 2.98B 3.11B 3.21B 3.32B 3.38B 3.41B 3.42B 3.4B 3.38B 3.38B 3.22B 3.01B 2.83B 2.59B 2.51B 2.46B 2.37B
Stock-Based Compensation
68M 152M 222M 283M 282M 272M 278M 292M 302M 305M 307M 309M 283M 257M 230M 204M 205M 201M
Other Working Capital
-1.38B -869M -231M 443M 404M -98M -844M -611M -969M -1.1B -442M -1.65B -1.04B -322M -768M -851M -358M 510M
Other Non-Cash Items
574M 535M 387M 394M 396M 437M 560M 502M 563M 472M 550M 1.03B 863M 950M 957M 522M 642M 542M
Deferred Income Tax
-1B -1.03B -1.01B -1.68B -1.58B -1.41B -1.3B -764M -722M -802M -995M -813M -700M -769M -406M -511M -541M -487M
Change in Working Capital
-1.53B -1.02B -379M 750M 711M 209M -537M -1.22B -1.58B -1.71B -1.05B -2.44B -1.83B -1.11B -1.56B -1.1B -1.11B -641M
Operating Cash Flow
7.58B 8.14B 8.67B 9.1B 9.35B 8.93B 8.41B 8.17B 7.69B 7.68B 9.15B 8.36B 9.07B 9.77B 9.54B 10.19B 10.25B 9.91B
Capital Expenditures
-1.41B -1.42B -1.4B -1.32B -1.39B -1.37B -1.48B -1.62B -1.84B -2.06B -2.24B -2.52B -2.5B -2.54B -2.52B -2.28B -2.12B -1.85B
Cash Acquisitions
-3.11B -3.1B -3.09B -3.08B -878M -941M -3.65B -3.65B -2.74B -2.69B -21M -17.9B -18B -18.09B -19.39B -1.55B -1.46B -1.38B
Purchase of Investments
-598M -571M -2.06B -2.06B -1.78B -1.76B -2M -2M -2M -2M n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
92M 139M 203M 203M 111M 64M 2M 2M 2M 2M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
653M 605M 513M 31M 90M -27M -14M -13M -72M 115M 105M 101M 102M 23M -14M -34M -35M -22M
Investing Cash Flow
-4.37B -4.34B -5.84B -6.24B -3.84B -4.03B -5.14B -5.29B -4.66B -4.63B -2.16B -20.33B -20.4B -20.6B -21.93B -3.87B -3.62B -3.25B
Debt Repayment
-2.39B -1.61B -2.4B -1.21B 1.87B 546M -155M 4.64B 2.67B 2.17B 654M 5.76B 8.88B 10.71B 8.91B 317M -3.52B -2.3B
Common Stock Repurchased
-3B -3B -4B -3B -3B -3B -3B -4B -4.01B -4.01B -3.01B -2.11B -2.1B -2.1B -2.1B -2.03B -2.03B -2.03B
Dividend Paid
-610M -597M -583M -570M -555M -541M -523M -504M -487M -469M -455M -441M -425M -411M -395M -379M -364M -348M
Other Financial Acitivies
53M 131M 195M 226M 177M 145M 56M 62M 12M -4M -58M -159M -136M -148M -74M 6M -10M -9M
Financial Cash Flow
-5.95B -5.07B -6.79B -4.55B -1.51B -2.85B -3.62B 197M -1.81B -2.26B -2.81B 3.27B 6.46B 8.29B 6.58B -1.94B -5.77B -4.51B
Net Cash Flow
-2.5B -1.35B -4.06B -1.5B 3.94B 2.02B -440M 3.23B 1.25B 721M 4.05B -9.11B -5.13B -2.82B -5.84B 4.48B 1.2B 2.59B
Free Cash Flow
6.17B 6.72B 7.27B 7.78B 7.96B 7.56B 6.93B 6.55B 5.85B 5.62B 6.91B 5.83B 6.57B 7.23B 7.02B 7.92B 8.13B 8.06B